Laura Sutcliffe
Stock Analyst at Citigroup
(1.08)
# 4,163
Out of 5,182 analysts
12
Total ratings
41.67%
Success rate
-8.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $345 → $340 | $230.26 | +47.66% | 5 | Apr 9, 2026 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $22 → $23 | $11.24 | +100.18% | 4 | Feb 24, 2026 | |
| ARGX argenx SE | Initiates: Buy | $390 | $809.27 | -51.81% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $28.56 | - | 2 | Dec 20, 2019 |
ResMed
Apr 9, 2026
Maintains: Buy
Price Target: $345 → $340
Current: $230.26
Upside: +47.66%
Telix Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $22 → $23
Current: $11.24
Upside: +100.18%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $809.27
Upside: -51.81%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $28.56
Upside: -